| 1 | [SID56463084] | Active | AbsAC26_uM | 0.0778 | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_Dose_CherryPick_Activity [AID624491, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | AbsAC26_uM | 0.0778 [uM] | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624491 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID56463084] | Active | AbsAC35_uM | 0.37 | Counterscreen for inhibitors of NLG for Luciferase Activators Measured in Cell-Based System Using Plate Reader - 2146-03_Inhibitor_Dose_CherryPick_Activity [AID624404, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | AbsAC35_uM | 0.37 [uM] | | BioAssay | Counterscreen for inhibitors of NLG for Luciferase Activators Measured in Cell-Based System Using Plate Reader - 2146-03_Inhibitor_Dose_CherryPick_Activity | | AID | 624404 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID56463084] | Active | IC50 | 0.951 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | IC50 | 0.951 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 4 | [SID56463084] | Active | IC50 | 0.951 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | IC50 | 0.951 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 5 | [SID56463084] | Active | IC50 | 0.951 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | IC50 | 0.951 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 6 | [SID56463084] | Active | Potency | 1.4125 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 7 | [SID56463084] | Active | Potency | 1.4125 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 8 | [SID56463084] | Active | AC50 | 1.42 | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity [AID624132, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | AC50 | 1.42 [uM] | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624132 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID56463084] | Active | IC50 | 2.24 | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3):Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID624395, Type: confirmatory] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | IC50 | 2.24 [uM] | | BioAssay | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3):Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 624395 | | BioAssay type | confirmatory | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 10 | [SID56463084] | Active | Potency | 3.1623 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 11 | [SID56463084] | Active | Potency | 3.1623 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 12 | [SID56463084] | Active | AC50 | 5.95 | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity [AID624133, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | AC50 | 5.95 [uM] | | BioAssay | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity | | AID | 624133 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID56463084] | Active | Potency | 8.1995 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 14 | [SID56463084] | Active | Potency | 8.1995 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 15 | [SID56463084] | Active | Potency | 8.1995 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 16 | [SID56463084] | Active | Potency | 9.2 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID56463084] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID56463084] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID56463084] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID56463084] | Active | Potency | 29.0929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 29.0929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID56463084] | Active | Potency | 29.0929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 29.0929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID56463084] | Active | Potency | 29.0929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | Potency | 29.0929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 23 | [SID56463084] | Active | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 24 | [SID56463084] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 25 | [SID56463084] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 26 | [SID56463084] | Active | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 27 | [SID56463084] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 28 | [SID56463084] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 29 | [SID56463084] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 30 | [SID56463084] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 31 | [SID56463084] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 32 | [SID56463084] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 33 | [SID56463084] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 34 | [SID56463084] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 35 | [SID56463084] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 36 | [SID56463084] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 37 | [SID56463084] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 38 | [SID56463084] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay [AID504607, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay | | AID | 504607 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID56463084] | Active | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID56463084] | Active | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Active | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID56463084] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 42 | [SID56463084] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 43 | [SID56463084] | Inactive | Potency | 3.1623 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Inactive | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 44 | [SID56463084] | Inactive | Potency | 19.9526 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 45 | [SID56463084] | Inactive | Potency | 25.1189 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 46 | [SID56463084] | Inactive | Potency | 25.1189 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 47 | [SID56463084] | Inactive | Potency | 25.1189 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 48 | [SID56463084] | Inactive | Potency | 25.1189 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 49 | [SID56463084] | Inactive | Potency | 35.4813 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 50 | [SID56463084] | Inactive | Potency | 35.4813 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56463084 | | CID | 23679527 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|